Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 135 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.
CSPHF stock price ended at $0 on Monday, after dropping NaN%
On the latest trading day May 25, 2026, the stock price of CSPHF fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for CSPHF decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
CSPHF Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
CSPHF currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for CSPHF
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for CSPHF. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to CSPHF?
According to technical analysis, CStone Pharmaceuticals has an aggregate signal of Neutral. CStone Pharmaceuticals has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What is the RSI for CStone Pharmaceuticals?
The RSI for CStone Pharmaceuticals is currently 0, indicating a neutral condition
What is CStone Pharmaceuticals price for the next 12 months?
CStone Pharmaceuticals CSPHF price for the next 12 months is estimated at $0.
How high is CStone Pharmaceuticals expected to go?
According to wall street analysts, CStone Pharmaceuticals is expected to reach a high forecast of $0.